Skip to main content

and
  1. Article

    Open Access

    Dengue virus-pandemic influenza virus co-infection results in enhanced influenza virus replication through inhibition of apoptosis

    Thomas G Voss, Mei-Chun Chen, Gena J Nichols, Somanna K Naveen in Retrovirology (2012)

  2. Article

    Open Access

    Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease

    Nipah virus (NiV) is a highly pathogenic zoonotic agent in the family Paramyxoviridae that is maintained in nature by bats. Outbreaks have occurred in Malaysia, Singapore, India, and Bangladesh and have been asso...

    Chad E Mire, Krista M Versteeg, Robert W Cross, Krystle N Agans in Virology Journal (2013)

  3. Article

    Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

    Thomas Geisbert and colleagues show that a cocktail of monoclonal antibodies protects cynomolgus monkeys from lethal Lassa fever virus infection, including when administration is delayed by more than a week af...

    Chad E Mire, Robert W Cross, Joan B Geisbert, Viktoriya Borisevich in Nature Medicine (2017)

  4. Article

    Erratum: Post-exposure treatments for Ebola and Marburg virus infections

    Nature Reviews Drug Discovery (2018); 10.1038/nrd.2017.251 The discussion of the phase II trial of TKM-130803 reported in reference 156 has been revised to correct inaccuracies in the original text.

    Robert W. Cross, Chad E. Mire, Heinz Feldmann in Nature Reviews Drug Discovery (2018)

  5. Article

    Post-exposure treatments for Ebola and Marburg virus infections

  6. The filoviruses, Ebola virus and Marburg virus, cause lethal haemorrhagic fever in humans and non-human primates (NHPs), and there are currently no licensed va...

  7. Robert W. Cross, Chad E. Mire, Heinz Feldmann in Nature Reviews Drug Discovery (2018)

  8. Article

    Open Access

    Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase

    We recently reported the development of the first African green monkey (AGM) model for COVID-19 based on a combined liquid intranasal (i.n.) and intratracheal (i.t.) exposure to severe acute respiratory syndro...

    Robert W. Cross, Krystle N. Agans, Abhishek N. Prasad in Virology Journal (2020)

  9. Article

    Establishment of an African green monkey model for COVID-19 and protection against re-infection

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an unprecedented global pandemic of COVID-19. Animal models are urgently needed to study the pathogenesis of COVID-19 and to scre...

    Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad in Nature Immunology (2021)

  10. Article

    Open Access

    A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

    Nipah and Hendra viruses are highly pathogenic bat-borne paramyxoviruses recently included in the WHO Blueprint priority diseases list. A fully registered horse anti-Hendra virus subunit vaccine has been in us...

    Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert in npj Vaccines (2021)

  11. Article

    Open Access

    Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge

    Junin virus (JUNV) is a pathogen of biodefense importance due to its potential for aerosol transmission and mortality rates reaching 30%. Currently, there are no JUNV vaccines licensed by the United States Foo...

    Teresa E. Sorvillo, Robert W. Cross, Dylan M. Johnson, Natalie S. Dobias in npj Vaccines (2021)